Bath & Body Works Inc. Q1 2026 Earnings Recap

The stock rose 14.8% following Q1 results, driven by better-than-expected sales and earnings per share despite ongoing pressure in underlying business trends. Investor enthusiasm appears tied to early signs of success from the company’s innovation and brand revitalization strategy, with confidence growing in long-term transformation plans.

Key Takeaways

• Net sales declined 3% but still came in above expectations, indicating less softness than feared.
• Adjusted EPS of $0.32 also beat estimates, contributing to positive investor reaction.
• Strong early consumer acceptance of new product launches highlighted by double-digit increases in average unit retail and SKU productivity for the new formulas.
• Body Care segment underperformed due to planned assortment changes and overcorrection on luxury franchise assortment, though swift remediation efforts are underway.
• Management reaffirmed full year 2026 sales and EPS guidance, emphasizing this is an early phase of a multi-year turnaround focused on product innovation and brand modernization.